PMID- 21046563 OWN - NLM STAT- MEDLINE DCOM- 20110926 LR - 20151119 IS - 1097-4547 (Electronic) IS - 0360-4012 (Linking) VI - 89 IP - 1 DP - 2011 Jan TI - Inhibition of hexokinase leads to neuroprotection against excitotoxicity in organotypic hippocampal slice culture. PG - 96-107 LID - 10.1002/jnr.22525 [doi] AB - During seizures, glucose concentrations are high in the hippocampus. Mitochondrial hexokinase (HK) catalyzes the first essential step of glucose metabolism and directly couples extramitochondrial glycolysis to intramitochondrial oxidative phosphorylation. The neuroprotective effects of an HK inhibitor, 3-bromopyruvate (3-BrPA), on kainic acid (KA)-induced excitotoxic injury were investigated. Hippocampal slices were prepared from hippocampi of 6-8-day-old rats using a tissue chopper and placed on a membrane insert. After a treatment with KA (5 muM) for 15 hr, neuronal death was quantified by propidium iodide (PI), cresol violet, and TUNEL staining. KA-induced cell death was significantly prevented by 30 muM 3-BrPA treatment. According to Western blots, the expression level of phospho-Akt increased after 3-BrPA treatment. The induction of long-term potentiation (LTP) at 48 hr after 3-BrPA treatment tended to increase in the CA1 area compared with the KA-only group, but the difference was not significant. Blocking the PI3 kinase/Akt pathway using LY294002 reversed the neuroprotective effect of 3-BrPA. These results suggest that inhibition of HK may play a protective role against neuronal death in KA-induced excitotoxic injury. CI - (c) 2010 Wiley-Liss, Inc. FAU - Lee, Kyung Hee AU - Lee KH AD - Department of Dental Hygiene, Division of Health Science, Dongseo University, Busan, Korea. FAU - Park, Ji Ho AU - Park JH FAU - Won, Ran AU - Won R FAU - Lee, Hyejung AU - Lee H FAU - Nam, Taick Sang AU - Nam TS FAU - Lee, Bae Hwan AU - Lee BH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Neurosci Res JT - Journal of neuroscience research JID - 7600111 RN - 0 (Neuroprotective Agents) RN - 0 (Neurotoxins) RN - 0 (Pyruvates) RN - 63JMV04GRK (bromopyruvate) RN - EC 2.7.1.1 (Hexokinase) SB - IM MH - Animals MH - Animals, Newborn MH - Cell Death/drug effects MH - Hexokinase/*antagonists & inhibitors/physiology MH - Nerve Degeneration/*drug therapy/*enzymology/pathology MH - Neurons/*drug effects/enzymology/pathology MH - Neuroprotective Agents/*pharmacology/therapeutic use MH - Neurotoxins/*antagonists & inhibitors MH - Organ Culture Techniques MH - Pyruvates/pharmacology/therapeutic use MH - Rats MH - Rats, Sprague-Dawley EDAT- 2010/11/04 06:00 MHDA- 2011/09/29 06:00 CRDT- 2010/11/04 06:00 PHST- 2010/11/04 06:00 [entrez] PHST- 2010/11/04 06:00 [pubmed] PHST- 2011/09/29 06:00 [medline] AID - 10.1002/jnr.22525 [doi] PST - ppublish SO - J Neurosci Res. 2011 Jan;89(1):96-107. doi: 10.1002/jnr.22525.